12 Health Care Stocks Moving In Tuesday's Intraday Session

Author: Benzinga Insights | August 01, 2023 01:31pm

Gainers

• Adamis Pharmaceuticals (NASDAQ:ADMP) shares increased by 170.2% to $3.86 during Tuesday's regular session. The current volume of 16.5 million shares is 10705.2% of Adamis Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:31 EST). The company's market cap stands at $10.7 million.
• ABVC BioPharma (NASDAQ:ABVC) stock moved upwards by 47.99% to $3.69. As of 13:31 EST, this security is trading at a volume of 10.3 million shares, making up 1841.4% of its average full-day volume over the last 100 days. The company's market cap stands at $12.1 million.
• Ampio Pharmaceuticals (AMEX:AMPE) stock increased by 24.21% to $0.29. The current volume of 17.7 million shares is 5749.3% of Ampio Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:31 EST). The market value of their outstanding shares is at $4.3 million.
• Rhythm Pharmaceuticals (NASDAQ:RYTM) shares increased by 23.99% to $22.12. The current volume of 1.7 million shares is 252.4% of Rhythm Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:31 EST). The market value of their outstanding shares is at $1.2 billion. As per the news, the Q2 earnings report came out today.
• EQRx (NASDAQ:EQRX) shares increased by 17.25% to $2.0. EQRx's stock is trading at a volume of 29.1 million shares as of 13:31 EST. This is 1506.7% of its average full-day volume over the last 100 days. The company's market cap stands at $977.1 million.
• Revolution Medicines (NASDAQ:RVMD) shares moved upwards by 15.82% to $30.41. Trading volume for this security as of 13:31 EST is 3.4 million, which is 390.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.2 billion.

Losers

• TG Therapeutics (NASDAQ:TGTX) stock fell 49.1% to $10.54 during Tuesday's regular session. Trading volume for TG Therapeutics's stock is 27.5 million as of 13:31 EST. This is 689.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.5 billion. As per the press release, Q2 earnings came out today.
• BioXcel Therapeutics (NASDAQ:BTAI) shares declined by 16.69% to $7.62. Trading volume for BioXcel Therapeutics's stock is 2.6 million as of 13:31 EST. This is 102.4% of its average full-day volume over the last 100 days. The company's market cap stands at $222.0 million.
• Adial Pharmaceuticals (NASDAQ:ADIL) stock declined by 15.89% to $0.27. Trading volume for Adial Pharmaceuticals's stock is 930.7K as of 13:31 EST. This is 40.0% of its average full-day volume over the last 100 days. The company's market cap stands at $8.0 million.
• OKYO Pharma (NASDAQ:OKYO) stock fell 15.51% to $1.58. Trading volume for OKYO Pharma's stock is 149.7K as of 13:31 EST. This is 88.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $40.3 million.
• eFFECTOR Therapeutics (NASDAQ:EFTR) stock decreased by 13.14% to $0.7. Trading volume for eFFECTOR Therapeutics's stock is 748.2K as of 13:31 EST. This is 34.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $43.3 million.
• Tarsus Pharmaceuticals (NASDAQ:TARS) shares decreased by 12.41% to $19.28. As of 13:31 EST, this security is trading at a volume of 537.7K shares, making up 178.5% of its average full-day volume over the last 100 days. The company's market cap stands at $516.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ABVC ADIL ADMP AMPE BTAI EFTR EQRX OKYO RVMD RYTM TARS TGTX